Literature DB >> 20356926

N-linked glycosylation is required for optimal proteolytic activation of membrane-bound transcription factor CREB-H.

Chi-Ping Chan1, To-Yuen Mak, King-Tung Chin, Irene Oi-Lin Ng, Dong-Yan Jin.   

Abstract

CREB-H is a liver-enriched bZIP transcription factor of the CREB3 subfamily. CREB-H is activated by intramembrane proteolysis that removes a C-terminal transmembrane domain. Aberrant expression of CREB-H is implicated in liver cancer. In this study we characterized N-linked glycosylation of CREB-H in the luminal domain at the C-terminus. We found that CREB-H is modified at three N-linked glycosylation sites in this region. Disruption of all three sites by site-directed mutagenesis completely abrogated N-linked glycosylation of CREB-H. The unglycosylated mutant of CREB-H was not unstable, unfolded or aggregated. Upon stimulation with an activator of intramembrane proteolysis such as brefeldin A and KDEL-tailed site 1 protease, unglycosylated or deglycosylated CREB-H was largely uncleaved, retained in an inactive form in the endoplasmic reticulum, and less capable of activating transcription driven by unfolded protein response element or C-reactive protein promoter. Taken together, our findings suggest that N-linked glycosylation is required for full activation of CREB-H through intramembrane proteolysis. Our work also reveals a novel mechanism for the regulation of CREB-H-dependent transcription.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20356926     DOI: 10.1242/jcs.067819

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  14 in total

Review 1.  The role of CREB-H transcription factor in triglyceride metabolism.

Authors:  Ann-Hwee Lee
Journal:  Curr Opin Lipidol       Date:  2012-04       Impact factor: 4.776

2.  REV7 is required for anaphase-promoting complex-dependent ubiquitination and degradation of translesion DNA polymerase REV1.

Authors:  Abel Chiu-Shun Chun; Kin-Hang Kok; Dong-Yan Jin
Journal:  Cell Cycle       Date:  2012-01-15       Impact factor: 4.534

3.  Transcriptional regulation of apolipoprotein A-IV by the transcription factor CREBH.

Authors:  Xu Xu; Jong-Gil Park; Jae-Seon So; Kyu Yeon Hur; Ann-Hwee Lee
Journal:  J Lipid Res       Date:  2014-03-05       Impact factor: 5.922

4.  Hepatic Sel1L-Hrd1 ER-associated degradation (ERAD) manages FGF21 levels and systemic metabolism via CREBH.

Authors:  Asmita Bhattacharya; Shengyi Sun; Heting Wang; Ming Liu; Qiaoming Long; Lei Yin; Sander Kersten; Kezhong Zhang; Ling Qi
Journal:  EMBO J       Date:  2018-11-02       Impact factor: 11.598

5.  β4GalT1 Mediates PPARγ N-Glycosylation to Attenuate Microglia Inflammatory Activation.

Authors:  Xiaojuan Liu; Aihong Li; Yuanyuan Ju; Wangrui Liu; Hui Shi; Renyue Hu; Zijian Zhou; Xiaolei Sun
Journal:  Inflammation       Date:  2018-08       Impact factor: 4.092

6.  CREB3 subfamily transcription factors are not created equal: Recent insights from global analyses and animal models.

Authors:  Chi-Ping Chan; Kin-Hang Kok; Dong-Yan Jin
Journal:  Cell Biosci       Date:  2011-02-17       Impact factor: 7.133

7.  The roles of post-translational modifications in the context of protein interaction networks.

Authors:  Guangyou Duan; Dirk Walther
Journal:  PLoS Comput Biol       Date:  2015-02-18       Impact factor: 4.475

8.  Transcriptional regulation of secretory capacity by bZip transcription factors.

Authors:  Rebecca M Fox; Deborah J Andrew
Journal:  Front Biol (Beijing)       Date:  2015-02-01

9.  Comparative analysis of the activation of unfolded protein response by spike proteins of severe acute respiratory syndrome coronavirus and human coronavirus HKU1.

Authors:  Kam-Leung Siu; Ching-Ping Chan; Kin-Hang Kok; Patrick C-Y Woo; Dong-Yan Jin
Journal:  Cell Biosci       Date:  2014-01-13       Impact factor: 7.133

10.  Analysis of transcription factor network underlying 3T3-L1 adipocyte differentiation.

Authors:  KyungOh Choi; Bassel Ghaddar; Colby Moya; Hai Shi; Gautham V Sridharan; Kyongbum Lee; Arul Jayaraman
Journal:  PLoS One       Date:  2014-07-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.